to FRC). That study also found a relationship between abnormally low MIP and longer time to wean. 4. What is novel and most important about this study (independent of exact "diagnosis" and correlation between MRC and MIP, which seem less compelling) is the ability to test MIP in such patients and have it correlate well with weaning duration (and important clinical issue). Perhaps this can be stressed / focused on more, as the most solid aspect of this analysis. 5. Figure 1 is interesting as it seems to display two separate cohorts (affected vs. unaffected?) shown in two quadrants of the scatter plot. First those with low MIP cluster around MRC <= 48 while those with normal strength almost always have good MIP. This is a core point of the paper. While this seems to validate the similar course of peripheral and respiratory muscle weakness (almost as a present vs. absent phenomenon), could this also represent bias in mental status (those with worse encephalopathy also may have artifactually lower MIP and lower MRC due to lack of cooperation). By only testing MRC when patients can follow commands reduces thi bias somewhat. Further exploration of these dichotomous populations may be warranted. 6. Those with lower MIP were clearly "sicker" with higher APACHE/SAPS. This would obviously necessitate longer ICU stays and longer weaning periods. Can the authors demonstrate that low MIP is an INDEPENDENT predictor of weakness/long weaning, even after controlling for the imbalance disease severities. I would focus on this aspect throughout the paper (if it turns out to be a useful test in the final analysis). 7. The relationship between ICU-AW (low MRC) and longer vent weans is not at all new (and not the objective of the study). It might keep the paper more focused (on MIP) if longer sections on how MRC predicts weaning, etc. were omitted (as repetitive, non-novel). This might include Figure 2 . Similarly Tables 1 and 2 could be simplified (e.g. comorbidities do not ALL need to be listed) and perhaps even combined (with two columns for the two groups). Minor issues: 1. What was the delay between MIP testing and mean first MRC testing? The authors state MRC testing was done within 48 hours if possible, but a significant number could never have MRC done "safely". How often, in the remainder, was the MRC within 48 hours of the MIP?
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General comments:
The report is interesting and well written. However, I am troubled by some of the assumptions that the authors make in the experimental design. 1. The diagnosis of CIPNM is established clinically by strength testing, rather than electrophysiological means. How can we be sure that all the patients who were weak had CIPNM, not myopathy, myasthenia gravis, or muscle wasting due to hypermetabolism/starvation? The authors cite appropriate references to justify their approach to the diagnosis, but I remain concerned that some of the patients in the study group did not have CIPNM but another cause of muscle weakness. 2. It is not surprising to me that respiratory muscle weakness correlates well with peripheral muscle weakness. I am concerned that lack of peripheral muscle effort also correlates with lack of respiratory effort. The authors address my concerns about lack of maximum efforts, but I would have liked to see an actual measurement of maximum inspiratory effort as well as performance. This study is limited by the small sample size, lack of diagnostic certainty, and reliance on maximum voluntary patient effort.
